Management of refractory hypoxemia during venovenous extracorporeal membrane oxygenation for ARDS

ASAIO Journal

Volumn 61, Issue 3, 2015, Pages 227-236

  Montisci, Andrea ^a   Maj, Giulia ^a   Zangrillo, Alberto ^a   Winterton, Dario ^a   Pappalardo, Federico ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

ARDS; ECMO; Hypoxemia

Indexed keywords

DIAGNOSIS; OXYGEN; OXYGENATION; RESPIRATORY THERAPY;

ACUTE RESPIRATORY DISTRESS SYNDROME; ARDS; ECMO; HEMOGLOBIN CONCENTRATION; HYPOXEMIA; NEUROMUSCULAR BLOCKING AGENTS; THERAPEUTIC HYPOTHERMIAS; VENOVENOUS EXTRACORPOREAL MEMBRANE OXYGENATION;

HEMOGLOBIN OXYGEN SATURATION;

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEMOGLOBIN; NEUROMUSCULAR BLOCKING AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; EXTRACORPOREAL OXYGENATION; HEMOGLOBIN DETERMINATION; HUMAN; HYPOXEMIA; INDUCED HYPOTHERMIA; LUNG FUNCTION; NEUROMUSCULAR BLOCKING; OXYGEN SATURATION; PATHOPHYSIOLOGY; PATIENT POSITIONING; PRIORITY JOURNAL; PULMONARY SHUNT; REVIEW; SEDATION; VENOUS RETURN; VENOVENOUS EXTRACORPOREAL MEMBRANE OXYGENATION; ANOXIA; COMPLICATION; PROCEDURES; RESPIRATORY DISTRESS SYNDROME, ADULT;

ANOXIA; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84937548861     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000207     Document Type: Review

References (67)

1. Ranieri VM, Rubenfeld GD, Thompson BT, et al. ARDS Definition Task Force: Acute respiratory distress syndrome: the Berlin Definition. JAMA. 307: 2526-2533, 2012
2. MacLaren G, Combes A, Bartlett RH. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med. 38: 210-220, 2012
3. Agerstrand CL, Bacchetta MD, Brodie D. ECMO for adult respiratory failure: current use and evolving applications. ASAIO J. 60: 255-262, 2014
4. Peek GJ, Mugford M, Tiruvoipati R, et al. CESAR trial collaboration: Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 374: 1351-1363, 2009
5. Davies A, Jones D, Bailey M, et al. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA. 302: 1888-1895, 2009
6. Davies A, Jones D, Gattas D. Extracorporeal membrane oxygenation for ARDS due to 2009 influenza A (H1N1) -Reply. JAMA. 303: 942, 2010
7. Extracorporeal Life Support Organization: ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support. Version 1.1. Ann Arbor, MI, April 2009
8. Zwischenberger JB, Bartlett RH. Management of blood flow and gas exchange during ECLS, in ECMO Extracorporeal Cardiopulmonary Support in Critical Care. 4th ed. Ann Arbor, MI: ELSO, 2012, pp. 149-156
9. Guarracino F, Zangrillo A, Ruggeri L, et al. Β-Blockers to optimize peripheral oxygenation during extracorporeal membrane oxygenation: a case series. J Cardiothorac Vasc Anesth. 26: 58-63, 2012
10. Schmidt M, Pellegrino V, Combes A, Scheinkestel C, Cooper DJ, Hodgson C. Mechanical ventilation during extracorporeal membrane oxygenation. Crit Care. 18: 203, 2014
11. Schumacker PT, Chandel N, Agusti AG. Oxygen conformance of cellular respiration in hepatocytes. Am J Physiol 265(4 Pt 1): L395-L402, 1993
12. Grocott MP, Martin DS, Levett DZ, McMorrow R, Windsor J, Montgomery HE; Caudwell Xtreme Everest Research Group: Arterial blood gases and oxygen content in climbers on Mount Everest. N Engl J Med. 360: 140-149, 2009
13. Krafft P, Fridrich P, Pernerstorfer T, et al. The acute respiratory distress syndrome: definitions, severity and clinical outcome. An analysis of 101 clinical investigations. Intensive Care Med. 22: 519-529, 1996
14. Abdelsalam M, Cheifetz IM. Goal-directed therapy for severely hypoxic patients with acute respiratory distress syndrome: permissive hypoxemia. Respir Care. 55: 1483-1490, 2010
15. Mikkelsen ME, Anderson B, Christie JD, Hopkins RO, Lanken PN. Can we optimizElong-Term outcomes in acute respiratory distress syndrome by targeting normoxemia?. Ann Am Thorac Soc. 11: 613-618, 2014
16. Mikkelsen ME, Christie JD, Lanken PN, et al. The adult respiratory distress syndrome cognitive outcomes study: long-Term neuropsychological function in survivors of acutElung injury. Am J Respir Crit Care Med. 185: 1307-1315, 2012
17. Hopkins RO, Weaver LK, Pope D, Orme JF, BigleReD, Larson-LOHR V. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med. 160: 50-56, 1999
18. Hopkins RO, Gale SD, Weaver LK. Brain atrophy and cognitive impairment in survivors of acute respiratory distress syndrome. Brain Inj. 20: 263-271, 2006
19. Mikkelsen ME, Anderson B, Christie JD, Hopkins RO, Lanken PN. Can we optimizElong-Term outcomes in acute respiratory distress syndrome by targeting normoxemia?. Ann Am Thorac Soc. 11: 613-618, 2014
20. Spiess BD. Perfluorocarbon emulsions as a promising technology: a review of tissue and vascular gas dynamics. J Appl Physiol (1985) 106: 1444-1452, 2009
21. Messaï E, Bouguerra A, Harmelin G, Di Lascio G, Cianchi G, Bonacchi M: A new formula for determining arterial oxygen saturation during venovenous extracorporeal oxygenation. Intensive Care Med. 39: 327-334, 2013
22. Sidebotham D, Allen SJ, McGeorge A, Ibbott N, Willcox T. Venovenous extracorporeal membrane oxygenation in adults: practicaLaspects of circuits, cannulae, and procedures. J Cardiothorac Vasc Anesth. 26: 893-909, 2012
23. Sidebotham D, McGeorge A, McGuinness S, Edwards M, Willcox T, Beca J. Extracorporeal membrane oxygenation for treating severe cardiac and respiratory disease in adults: part 1 -overview of extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth. 23: 886-892, 2009
24. Sidebotham D, McGeorge A, McGuinness S, Edwards M, Willcox T, Beca J. Extracorporeal membrane oxygenation for treating severe cardiac and respiratory failure in adults: part 2-Technical considerations. J Cardiothorac Vasc Anesth. 24: 164-172, 2010
25. Schmidt M, Tachon G, DevillierSc, et al. Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults. Intensive Care Med. 39: 838-846, 2013
26. Abrams D, Bacchetta M, Brodie D. Recirculation in venovenous extracorporeal membrane oxygenation. ASAIO Journal, 2014. [Epub ahead of print
27. Fortenberry JD, Pettignano R, Dykes F. Principles and practice of venovenous ECMO. in ECMO Extracorporeal Cardiopulmonary Support in Critical Care, 3rd ed., Ann Arbor, MI, Extracorporeal Life Support Organization, 2005 p. 94
28. Walker JL, Gelfond J, Zarzabal LA, Darling E. Calculating mixed venous saturation during veno-venous extracorporeal membrane oxygenation. Perfusion. 24: 333-339, 2009
29. Locker GJ, Losert H, Schellongowski P, et al. Bedside exclusion of clinically significant recirculation volume during venovenous ECMO using conventional blood gas analyses. J Clin Anesth. 15: 441-445, 2003
30. Rodríguez-Roisin R, Roca J. Mechanisms of hypoxemia. Intensive Care Med. 31: 1017-1019, 2005
31. Bachofen M, WeibeLeR. Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am Rev Respir Dis. 116: 589-615, 1977
32. Sangalli F, Patroniti N, Pesenti A. Basic aspects of physiology during ECMO support, in Sangalli (Ed): ECMO -Extracorporeal Life Support in Adults, Springer, 2014, pp. 19-36
33. West JB. Blood flow tOthElung and gas exchange. Anesthesiology. 41: 124-138, 1974
34. Lynch JP, Mhyre JG, Dantzker DR. Influence of cardiac output on intrapulmonary shunt. J Appl Physiol RespiRenviron Exerc Physiol. 46: 315-321, 1979
35. Dantzker DR, Lynch JP, Weg JG. Depression of cardiac output is a mechanism of shunt reduction in the therapy of acute respiratory failure. Chest. 77: 636-642, 1980
36. Toomasian JM, Bartlett RH. Hemolysis and ECMO pumps in the 21st Century. Perfusion. 26: 5-6, 2011
37. Paden ML, Conrad SA, Rycus PT, Thiagarajan RR. ELSO registry: extracorporeal life support organization registry report 2012. ASAIO J. 59: 202-10, 2013
38. Bartlett RH. Physiology of extracorporeal life support, in Annich GM, Lynch WR, MacLaren G, Wilson JM, Bartlett RH (Eds): ECMO Extracorporeal Cardiopulmonary Support in Critical Care. 4th ed. Ann Arbor, MI: ELSO, 2012: pp. 11-32
39. Netzer G, Shah CV, Iwashyna TJ, et al. Association of RBC transfusion with mortality in patients with acutElung injury. Chest. 132: 1116-1123, 2007
40. Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, Christiani DC. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med. 33: 1191-1198, 2005
41. Rich PB, Awad SS, Crotti S, Hirschl RB, Bartlett RH, Schreiner RJ: A prospective comparison of atrio-femoraLand femoro-Atrial flow in adult venovenous extracorporeal life support. J Thorac Cardiovasc Surg. 116: 628-632, 1998
42. Ichiba S, Peek GJ, Sosnowski AW, Brennan KJ, Firmin RK. Modifying a venovenous extracorporeal membrane oxygenation circuit to reduce recirculation. Ann Thorac Surg. 69: 298-299, 2000
43. Bonacchi M, Harmelin G, Peris A, Sani G: A novel strategy to improve systemic oxygenation in venovenous extracorporeal membrane oxygenation: the "configuration". J Thorac Cardiovasc Surg. 142: 1197-1204, 2011
44. Bermudez CA, Rocha RV, Sappington PL, Toyoda Y, Murray HN, Boujoukos AJ. InitiaLexperience with single cannulation for venovenous extracorporeal oxygenation in adults. Ann Thorac Surg. 90: 991-995, 2010
45. Camboni D, Philipp A, Lubnow M, et al. Extracorporeal membrane oxygenation by single-vesseLaccess in adults: advantages and limitations. ASAIO J. 58: 616-621, 2012
46. Papazian L, Forel JM, Gacouin A, et al. ACURASYS Study Investigators: Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 363: 1107-1116, 2010
47. Alhazzani W, Alshahrani M, Jaeschke R, et al. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-Analysis of randomized controlled trials. Crit Care. 17: R43, 2013
48. Polderman KH. Mechanisms of action, physiologicaLeffects, and complications of hypothermia. Crit Care Med. 37: S186-202, 2009
49. Villar J, Espinosa S. Adult respiratory distress syndrome and sepsis, in Tisherman AS, Stertz F (eds): Therapeutic Hypothermia, New York, Springer, 2005: pp.169-178
50. Villar J, Slutsky AS. Effects of induced hypothermia in patients with septic adult respiratory distress syndrome. Resuscitation. 26: 183-192, 1993
51. Wiest DB, Haney JS. Clinical pharmacokinetics and therapeutic efficacy of esmolol. Clin Pharmacokinet. 51: 347-356, 2012
52. Rudiger A, Singer M. The heart in sepsis: from basic mechanisms to clinical management. Curr Vasc Pharmacol. 11: 187-195, 2013
53. Hunter JD, Doddi M. Sepsis and the heart. Br J Anaesth. 104: 3-11, 2010
54. Macchia A, Romero M, Comignani PD, et al. Previous prescription of Β-blockers is associated with reduced mortality among patients hospitalized in intensive care units for sepsis. Crit Care Med. 40: 2768-2772, 2012
55. Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 310: 1683-1691, 2013
56. Gattinoni L, Carlesso E, Taccone P, Polli F, Guérin C, Mancebo J. Prone positioning improves survival in severe ARDS: a pathophysiologic review and individual patient meta-Analysis. Minerva Anestesiol. 76: 448-454, 2010
57. Dickinson S, Park PK, NapolitanOlM. Prone-positioning therapy in ARDS. Crit Care Clin. 27: 511-523, 2011
58. Guérin C, Reignier J, Richard JC, et al. PROSEVA Study Group: Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 368: 2159-2168, 2013
59. Guervilly C, Hraiech S, Gariboldi V, et al. Prone positioning during veno-venous extracorporeal membrane oxygenation for severe acute respiratory distress syndrome in adults. Minerva Anestesiol. 80: 307-313, 2014
60. Otterspoor LC, Smit FH, van Laar TJ, Kesecioglu J, van Dijk D. Prolonged use of extracorporeal membrane oxygenation combined with prone positioning in patients with acute respiratory distress syndrome and invasive Aspergillosis. Perfusion. 27: 335-337, 2012
61. Litmathe J, Sucker C, Easo J, Wigger L, Dapunt O. Prone and ECMO-A contradiction per se?. Perfusion. 27: 78-82, 2012
62. Kredel M, Bischof L, Wurmb TE, Roewer N, Muellenbach RM. Combination of positioning therapy and venovenous extracorporeal membrane oxygenation in ARDS patients. Perfusion. 29: 171-177, 2014
63. Javidfar J, Brodie D, Costa J, et al. Subclavian artery cannulation for venoarteriaLextracorporeal membrane oxygenation. ASAIO J. 58: 494-498, 2012
64. Vieillard-Baron A, PricElC, Matthay MA. Acute cor pulmonale in ARDS. Intensive Care Med. 39: 1836-1838, 2013
65. Boissier F, Katsahian S, Razazi K, et al. Prevalence and prognosis of cor pulmonale during protective ventilation for acute respiratory distress syndrome. Intensive Care Med. 39: 1725-1733, 2013
66. Cheng R, Hachamovitch R, Kittleson M, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shocKand cardiac arrest: a meta-Analysis of 1,866 adult patients. Ann Thorac Surg. 97: 610-616, 2014
67. Biscotti M, Lee A, Basner RC, Agerstrand C, Abrams D, Brodie D, et al. Hybrid configuration via percutaneous access foRextracorporeal membrane oxygenation: a single centeRexperience. ASAIO J. 60: 635-642, 2014